Comparison between IRCON International IPO and Metropolis Healthcare IPO.
IRCON International IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Metropolis Healthcare IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of IRCON International IPO is up to ₹466.93 Cr whereas the issue size of the Metropolis Healthcare IPO is up to ₹1,204.29 Cr. The final issue price of IRCON International IPO is ₹475.00 per share and of Metropolis Healthcare IPO is ₹880.00 per share.
| IRCON International IPO | Metropolis Healthcare IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹2 per share |
| Issue Price (Lower) | ₹470.00 per share | ₹877.00 per share |
| Issue Price (Upper) | ₹475.00 per share | ₹880.00 per share |
| Issue Price (Final) | ₹475.00 per share | ₹880.00 per share |
| Discount (Retail) | ₹10.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹10.00 per share | ₹0.00 per share |
| Market Lot Size | 30 shares | 17 shares |
| Fresh Issue Size | 0 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 99,05,157 shares | 1,36,85,095 shares |
| OFS Issue Size (Amount) | up to ₹466.93 Cr | up to ₹1,204.29 Cr |
| Issue Size Total | 99,05,157 shares | 1,36,85,095 shares |
| Issue Size Total (Amount) | up to ₹466.93 Cr | up to ₹1,204.29 Cr |
IRCON International IPO opens on Sep 17, 2018, while Metropolis Healthcare IPO opens on Apr 03, 2019. The closing date of IRCON International IPO and Metropolis Healthcare IPO is Sep 19, 2018, and Apr 05, 2019, respectively.
| IRCON International IPO | Metropolis Healthcare IPO | |
|---|---|---|
| Anchor Bid Date | Apr 02, 2019 | |
| Issue Open | Sep 17, 2018 | Apr 03, 2019 |
| Issue Close | Sep 19, 2018 | Apr 05, 2019 |
| Basis Of Allotment (Tentative) | Sep 25, 2018 | Apr 10, 2019 |
| Initiation of Refunds (Tentative) | Sep 26, 2018 | Apr 11, 2019 |
| Credit of Share (Tentative) | Sep 26, 2018 | Apr 12, 2019 |
| Listing date (Tentative) | Sep 28, 2018 | Apr 15, 2019 |
| Anchor Lockin End date 1 | May 10, 2019 | |
| Anchor Lockin End date 2 | Jul 09, 2019 |
IRCON International IPO P/E ratio is , as compared to Metropolis Healthcare IPO P/E ratio of .
| IRCON International IPO | Metropolis Healthcare IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 99.71 | |||||
| Promoter Shareholding (Post-Issue) | 49.44 | |||||
| P/E Ratio | ||||||
| Market Cap | ₹4467.45 Cr. | ₹4415.72 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the IRCON International IPO Retail Individual Investors (RII) are offered 32,91,805 shares while in Metropolis Healthcare IPO retail investors are offered 32,91,805 shares. Qualified Institutional Buyers (QIB) are offered 47,02,578 shares in IRCON International IPO and 40,15,529 shares in Metropolis Healthcare IPO.
| IRCON International IPO | Metropolis Healthcare IPO | |
|---|---|---|
| Anchor Investor Reservation | 60,23,293 shares | |
| Market Maker Reservation | ||
| QIB | 47,02,578 shares | 40,15,529 shares |
| NII | 14,10,774 shares | 20,07,764 shares |
| RII | 32,91,805 shares | 13,38,509 shares |
| Employee | 5,00,000 shares | 3,00,000 shares |
| Others | ||
| Total | 99,05,157 shares | 1,36,85,095 shares |
IRCON International IPO subscribed 9.77x in total, whereas Metropolis Healthcare IPO subscribed 5.83x.
| IRCON International IPO | Metropolis Healthcare IPO | |
|---|---|---|
| QIB (times) | 12.29x | 8.88x |
| NII (times) | 4.92x | 3.03x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 9.66x | 2.15x |
| Employee (times) | 0.36x | 0.05x |
| Other (times) | ||
| Total (times) | 9.77x | 5.83x |
